SensoryEffects, headquartered in St. Louis, Mo., provides customized, technology-driven food and beverage solutions, including ingredients, bases, and finished food systems, for leading multinational and emerging high-growth food and beverage customers. The company's solutions enhance vital sensory properties, such as taste, texture, solubility, aroma, and color, which make its customers' products more desirable to the end consumer.

Balchem is a leader in human and animal health nutrition, with value-added functional and solution-based ingredients and a public equity market capitalization of approximately $1.8 billion. Balchem's technologies apply across a broad spectrum of end markets, with a proprietary portfolio of solutions that differentiate products for commercial bakers, confectioners, flavor specialists, meat processors, nutraceutical and functional food producers, drug manufacturers, production and companion animals, and beyond.

Highlander Partners is a Dallas-based private investment firm with partners who have committed over $600 million of principal funds for direct private equity investments in North America and Central Europe. The firm focuses on making investments in middle-market businesses in targeted industries in which the principals of the firm have significant operating and investing experience, including basic manufacturing, food, building materials, and others. Highlander Partners uses a "buy and build" investment approach, creating value by helping companies grow organically and through acquisitions.

Houlihan Lokey is an international investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, and Asia. Independent advice and intellectual rigor are hallmarks of our commitment to client success across our advisory services. Houlihan Lokey is ranked as the No. 1 global restructuring advisor, the No. 1 M&A fairness opinion advisor for U.S. transactions over the past 10 years, and the No. 1 M&A advisor for U.S. transactions under $3 billion, according to Thomson Reuters.

If you would like more information about Houlihan Lokey, or if you have questions regarding this transaction, please contact one of the Houlihan Lokey team members listed.